Organicell Regenerative Medicine, Inc. (OTCMKTS:BPSR – Get Free Report)’s share price passed above its 50-day moving average during trading on Friday. The stock has a 50-day moving average of $1.25 and traded as high as $1.3668. Organicell Regenerative Medicine shares last traded at $1.36, with a volume of 7,684 shares.
Organicell Regenerative Medicine Stock Performance
The firm’s fifty day simple moving average is $1.25 and its two-hundred day simple moving average is $1.81.
About Organicell Regenerative Medicine
Organicell Regenerative Medicine, Inc is a biotechnology company focused on developing regenerative medicine products designed to support tissue repair and modulate inflammatory and immune responses. The company’s research centers on biologic therapies derived from human amniotic fluid and other perinatal sources.
Its principal product candidate is Zofin, an acellular biologic containing extracellular vesicles and other naturally occurring components found in amniotic fluid. Organicell has investigated Zofin for potential applications involving inflammation, immune-system regulation, and tissue regeneration, including research related to respiratory and other systemic conditions.
Organicell’s products remain under development, and investigational uses should not be interpreted as evidence of regulatory approval or established clinical effectiveness.
Further Reading
- Five stocks we like better than Organicell Regenerative Medicine
- Oracle’s AI Spending Peak Is in Sight—Can the Stock Recover?
- LyondellBasell’s Dividend Looks Safer, But a New Risk Could Change That
- L3Harris Stock Took a Beating—Is a 20% Rebound Next?
- Starbucks Says Its Turnaround Is Done—The Numbers Make a Strong Case (With 1 Catch)
Receive News & Ratings for Organicell Regenerative Medicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organicell Regenerative Medicine and related companies with MarketBeat.com's FREE daily email newsletter.
